Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Mitochondria

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

Mitochondrial Membranes

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...

The Inner Mitochondrial Membrane

The Inner Mitochondrial Membrane

The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<sup>19</sup>F-NMR spectroscopy of fluorinated isoleucine analogues in a protein.

Journal of biomolecular NMR·2026

Same author

Asymmetric Partial Reductions of Pyridines.

Trends in chemistry·2025

Same author

Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic.

Journal of clinical medicine·2025

Same author

Discovery and validation of small molecule stabilizers of mutant triose phosphate isomerase (TPI) as potential lead candidates for TPI deficiency.

SLAS discovery : advancing life sciences R & D·2025

Same author

<i>In vivo</i> manipulation of the protein homeostasis network in rhabdomyosarcoma.

Oncotarget·2025

Same author

Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric Inhibitors.

Journal of medicinal chemistry·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

Mitochondria as a target in treatment.

Marie-Céline Frantz¹, Peter Wipf

¹Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. maf135@pitt.edu

Environmental and Molecular Mutagenesis

|February 23, 2010

Summary

Mitochondria are vital organelles targeted by new drugs for metabolic and degenerative diseases. Delivering antioxidants directly into mitochondria offers a promising therapeutic strategy for controlling cellular redox balance.

Area of Science:

Cellular Biology
Mitochondrial Medicine
Drug Discovery

Background:

Mitochondria are central to cellular functions, including cell death and survival.
Dysfunctional mitochondria are implicated in metabolic, degenerative, and hyperproliferative diseases.
Mitochondria are attractive targets for therapeutic intervention.

Purpose of the Study:

To review emerging strategies for targeting mitochondria with therapeutic agents.
To explore the concept of delivering antioxidants to mitochondria to control reactive oxygen species (ROS) balance.
To summarize recent medicinal chemistry and clinical data on mitochondrial-targeted therapeutics.

Main Methods:

Review of recent medicinal chemistry literature.
Analysis of clinical data for mitochondrial-targeted therapies.

More Related Videos

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

Related Experiment Videos

Last Updated: Jun 16, 2026

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides

Published on: September 16, 2020

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

Exploration of organelle-specific drug delivery and prodrug strategies.

Main Results:

Mitochondria-specific agents and prodrugs are effective therapeutic strategies.
Selective delivery of antioxidants into mitochondria is an emerging concept for ROS balance.
Recent data show promise for these exploratory mitochondrial-targeting strategies.

Conclusions:

Targeting mitochondria offers a viable approach for treating various diseases.
Mitochondrial drug delivery, particularly antioxidants, represents a future therapeutic direction.
Further research and clinical data are needed to advance mitochondrial therapeutics.